{"id":"https://openalex.org/W2560079614","doi":"https://doi.org/10.1182/blood.v116.21.4638.4638","title":"Ofatumumab and High-Dose Methylprednisolone Is An Effective Salvage Treatment for Heavily Pretreated, Unfit or Refractory Patients with Chronic Lymphocytic Leukemia: Single Institution Experience","display_name":"Ofatumumab and High-Dose Methylprednisolone Is An Effective Salvage Treatment for Heavily Pretreated, Unfit or Refractory Patients with Chronic Lymphocytic Leukemia: Single Institution Experience","publication_year":2010,"publication_date":"2010-11-19","ids":{"openalex":"https://openalex.org/W2560079614","doi":"https://doi.org/10.1182/blood.v116.21.4638.4638","mag":"2560079614"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v116.21.4638.4638","doi":"https://doi.org/10.1182/blood.v116.21.4638.4638","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.4638.4638","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013814515","display_name":"Januario E. Castro","orcid":"https://orcid.org/0000-0003-2785-0892","observed_orcids":["https://orcid.org/0000-0003-2785-0892"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Januario E Castro","raw_affiliation_strings":["Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036610843","display_name":"Juan Sebastian Barajas-Gamboa","orcid":"https://orcid.org/0000-0003-4158-4893","observed_orcids":["https://orcid.org/0000-0003-4158-4893"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Juan Sebastian Barajas-Gamboa","raw_affiliation_strings":["Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047903125","display_name":"Johanna Melo\u2010Cardenas","orcid":"https://orcid.org/0000-0002-5122-3349","observed_orcids":["https://orcid.org/0000-0002-5122-3349"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Johanna Melo-Cardenas","raw_affiliation_strings":["Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054460483","display_name":"Rosa N Paz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rosa N Paz","raw_affiliation_strings":["Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018305611","display_name":"Cesar Bernal-Corzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cesar Bernal-Corzo","raw_affiliation_strings":["Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023020809","display_name":"Amine Ale-Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amine Ale-Ali","raw_affiliation_strings":["Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081161234","display_name":"Danelle Frances James","orcid":"https://orcid.org/0000-0002-4434-8960","observed_orcids":["https://orcid.org/0000-0002-4434-8960"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Danelle F. James","raw_affiliation_strings":["Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, UCSD, La Jolla, CA, USA,","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, The University of California, San Diego, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Moores-UCSD Cancer Center, University of California, San Diego, San Diego, CA, The University of California, San Diego, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5013814515","https://openalex.org/A5018305611","https://openalex.org/A5036610843","https://openalex.org/A5047903125","https://openalex.org/A5054460483","https://openalex.org/A5081161234"],"corresponding_institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.9767,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.87685471,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":98},"biblio":{"volume":"116","issue":"21","first_page":"4638","last_page":"4638"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":0.9599999785423279},{"id":"https://openalex.org/keywords/high-dose-methylprednisolone","display_name":"high-dose methylprednisolone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.875},{"id":"https://openalex.org/keywords/fludarabine-refractory-disease","display_name":"fludarabine-refractory disease","score":0.859000027179718},{"id":"https://openalex.org/keywords/high-risk-disease","display_name":"high-risk disease","score":0.4869999885559082},{"id":"https://openalex.org/keywords/bulky-disease","display_name":"bulky disease","score":0.5839999914169312},{"id":"https://openalex.org/keywords/treatment-safety-and-toxicity","display_name":"treatment safety and toxicity","score":0.656000018119812},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.3199999928474426},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.39899998903274536},{"id":"https://openalex.org/keywords/unmutated-igvh","display_name":"unmutated IgVH","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8771330118179321},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.8276195526123047},{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.780989408493042},{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.7076312303543091},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7055421471595764},{"id":"https://openalex.org/C2780372218","wikidata":"https://www.wikidata.org/wiki/Q417222","display_name":"Methylprednisolone","level":2,"score":0.6405980587005615},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5795661211013794},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5179640054702759},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.46487975120544434},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.44473904371261597},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.44109973311424255},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.43793782591819763},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4367104768753052},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4204515814781189},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3626202344894409},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.3375207781791687},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2858208417892456},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.10514861345291138},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.09586158394813538},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v116.21.4638.4638","doi":"https://doi.org/10.1182/blood.v116.21.4638.4638","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.4638.4638","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2169370552","https://openalex.org/W2589120779","https://openalex.org/W2591412714","https://openalex.org/W2055504914","https://openalex.org/W2029903885","https://openalex.org/W2980502945","https://openalex.org/W2587738153","https://openalex.org/W2597688858","https://openalex.org/W1979497236","https://openalex.org/W2911376981"],"abstract_inverted_index":{"Abstract":[0,1],"4638":[2],"High-dose":[3],"methylprednisolone":[4],"(HDMP)":[5],"and":[6,44,80,135,174,210,212,243,268,330,362,368,395,410,415,440,467],"the":[7,40,76,171,182,233,249,255,278,291,313,374,380,396,406,436,452],"fully":[8],"human":[9],"monoclonal":[10],"anti-CD":[11],"20":[12],"Ofatumumab":[13,81,411,441,468],"each":[14],"can":[15],"produce":[16],"partial":[17,387],"responses":[18],"in":[19,60,82,350,357,366,442],"CLL,":[20],"even":[21,331],"though":[22],"complete":[23],"remissions":[24],"are":[25,63,503],"not":[26,87,426,471],"often":[27],"observed":[28,434],"following":[29],"treatment":[30,50,74,95,345,469,484],"with":[31,114,120,161,186,229,260,316,333,340,451,473],"either":[32],"agent":[33],"alone.":[34],"Previously":[35],"we":[36],"have":[37,206,225],"reported":[38],"that":[39,62,85,205,215,379,405,423],"combination":[41,51,77,407,437,502],"of":[42,73,78,152,177,181,190,197,232,254,265,271,290,308,327,360,390,408,438,445,454,500,509],"Rituximab":[43],"HDMP":[45,79,121,209,409,439,466],"is":[46,412,478],"an":[47],"effective":[48,416],"non-myelosuppressive":[49],"for":[52,93,131,419,428,435,483,493],"previously":[53,208,227],"untreated":[54],"CLL":[55,83,117,421,495],"patients":[56,61,84,113,183,204,214,224,234,256,292,311,332,346,391,422,446,455],"as":[57,59],"well":[58],"fludarabine":[64,109,240],"refractory.":[65],"We":[66],"report":[67],"here":[68],"our":[69],"single":[70],"institution":[71],"experience":[72,347],"using":[75],"were":[86,118,168,184,237,425],"considered":[88],"to":[89,97,108,169,239,448,459,511],"be":[90,449],"good":[91],"candidates":[92,427],"chemotherapy":[94],"due":[96],"comorbidities,":[98],"poor":[99],"performance":[100],"status,":[101],"profound":[102],"cytopenias":[103],"or":[104,236,304,321,461],"because":[105],"refractory":[106],"status":[107],"and/or":[110,241],"alemtuzumab.":[111],"Eight":[112],"progressive,":[115],"symptomatic":[116],"treated":[119,228],"1":[122,147],"g/m2":[123],"IV":[124],"daily":[125],"\u00d7":[126],"3":[127],"every":[128],"28":[129],"days":[130],"three":[132],"consecutive":[133],"cycles,":[134],"ofatumumab":[136],"administered":[137],"based":[138,372],"on":[139,373],"package":[140],"insert":[141],"instructions":[142],"(300":[143],"mg":[144,154],"dose":[145],"#":[146],"followed":[148],"by":[149,248],"11":[150],"doses":[151],"2,000":[153],"over":[155],"a":[156,187,363,413,457,479,489],"6":[157],"month":[158],"period)":[159],"along":[160],"prophylactic":[162],"antimicrobial":[163],"therapy.":[164],"The":[165,195,282,431],"main":[166],"objectives":[167],"determine":[170],"safety,":[172],"toxicity":[173],"clinical":[175,498],"efficacy":[176],"this":[178,341,443,487,501],"regimen.":[179,343],"All":[180,223,310],"males":[185],"median":[188,196,261,269,283],"age":[189],"69":[191],"years":[192],"(range":[193,275],"49\u201378).":[194],"prior":[198],"treatments":[199],"was":[200,286,324,384,470],"4.5":[201],"including":[202,297],"4":[203],"received":[207],"rituximab":[211],"two":[213],"underwent":[216],"matched":[217],"unrelated":[218],"donor":[219],"stem":[220],"cell":[221,354],"transplant.":[222],"been":[226],"rituximab,":[230],"75%":[231,289],"failed":[235],"intolerant":[238],"aletuzumab":[242],"88%":[244],"had":[245,257,293,392],"high-risk":[246,294,420,494],"disease":[247,259,394,463],"modified":[250],"Rai":[251],"classification.":[252],"Most":[253],"bulky":[258],"lymph":[262],"node":[263],"product":[264],"42":[266],"cms2":[267],"splenomegaly":[270],"6.":[272],"5":[273],"cm":[274],"0\u201317)":[276],"below":[277],"left":[279],"costal":[280],"margin.":[281],"lymphocyte":[284],"count":[285],"28,000":[287],"cells/mm3.":[288],"prognostic":[295],"markers":[296],"unfavorable":[298],"cytogenetics,":[299],"unmutated":[300],"IgVH":[301],"region":[302],"genes":[303],"high":[305],"expression":[306],"levels":[307],"ZAP-70.":[309],"completed":[312],"planned":[314],"therapy":[315,460],"no":[317,325],"major":[318,480],"side":[319],"effects":[320],"toxicities.":[322],"There":[323],"evidence":[326],"marrow":[328,475],"suppression":[329],"pancytopenia":[334],"improved":[335],"their":[336],"peripheral":[337,351],"blood":[338,353],"counts":[339],"salvage":[342,417],"During":[344],"significant":[348],"decrease":[349],"white":[352],"counts,":[355],"increase":[356],"hemoglobin,":[358],"elevation":[359],"platelets":[361],"dramatic":[364],"reduction":[365],"lymphadenopathy":[367],"splenomegaly.":[369],"Response":[370],"assessment":[371],"IW-CLL":[375],"2008":[376],"criteria":[377],"showed":[378,398],"overall":[381],"response":[382,432,458],"rate":[383],"50%":[385],"(4":[386],"remissions),":[388],"25%":[389],"stable":[393],"remainder":[397],"progressive":[399],"disease.":[400],"Overall,":[401],"these":[402],"data":[403],"suggest":[404],"safe":[414],"regimen":[418,488],"otherwise":[424],"additional":[429],"treatment.":[430],"rates":[433],"group":[444],"appear":[447],"favorable":[450],"majority":[453],"achieving":[456],"experiencing":[462],"stabilization.":[464],"Moreover,":[465],"associated":[472],"bone":[474],"suppression,":[476],"which":[477],"limiting":[481],"factor":[482],"administration,":[485],"making":[486],"potential":[490],"valid":[491],"alternative":[492],"patients.":[496],"Additional":[497],"studies":[499],"warranted.":[504],"Disclosures:":[505],"No":[506],"relevant":[507],"conflicts":[508],"interest":[510],"declare.":[512]},"counts_by_year":[{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-12-16T00:00:00"}